Abstract:Peripheral neuropathies are characterized by nerves damage and axonal loss, and they could be classified in hereditary or acquired forms. Acquired peripheral neuropathies are associated with several causes, including toxic agent exposure, among which the antineoplastic compounds are responsible for the so called Chemotherapy-Induced Peripheral Neuropathy (CIPN). Several clinical features are related to the use of anticancer drugs which exert their action by affecting different mechanisms and structures of the peripheral nervous system: the axons (axonopathy) or the dorsal root ganglia (DRG) neurons cell body (neuronopathy/ganglionopathy). In addition, antineoplastic treatments may affect the blood brain barrier integrity, leading to cognitive impairment that may be severe and long-lasting. CIPN may affect patient quality of life leading to modification or discontinuation of the anticancer therapy. Although the mechanisms of the damage are not completely understood, several hypotheses have been proposed, among which neuroinflammation is now emerging to be relevant in CIPN pathophysiology. In this review, we consider different aspects of neuro-immune interactions in several CIPN preclinical studies which suggest a critical connection between chemotherapeutic agents and neurotoxicity. The features of the neuroinflammatory processes may be different depending on the type of drug (platinum derivatives, taxanes, vinca alkaloids and proteasome inhibitors). In particular, recent studies have demonstrated an involvement of the immune response (both innate and adaptive) and the stimulation and secretion of mediators (cytokines and chemokines) that may be responsible for the painful symptoms, whereas glial cells such as satellite and Schwann cells might contribute to the maintenance of the neuroinflammatory process in DRG and axons respectively. Moreover, neuroinflammatory components have also been shown in the spinal cord with microglia and astrocytes playing an important role in CIPN development. Taking together, better understanding of these aspects would permit the development of possible strategies in order to improve the management of CIPN.

The Role of Neuro-Inflammation and Innate Immunity in Pathophysiology of Brain and Spinal Cord Tumors

Neuroscience in Peripheral Cancers: Tumors Hijacking Nerves and Neuroimmune Crosstalk

CNS and CNS Diseases in Relation to Their Immune System

Neural control of tumor immunity

Neural Circuitries between the Brain and Peripheral Solid Tumors

Nerve Growth Factor and the Role of Inflammation in Tumor Development

Neuroimmunology of cancer and associated symptomology

The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy

The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors

Emerging Roles of the Nervous System in Gastrointestinal Cancer Development

Cancer neuroscience: State of the field, emerging directions

Biological Insights and Radiation–Immuno–Oncology Developments in Primary and Secondary Brain Tumors

Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy

Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications

Progress in cancer neuroscience

Neuroinflammation in the Brain and Role of Intestinal Microbiota: An Overview of the Players

Targeting Innate Immunity in Glioma Therapy

The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy

Immune cell infiltration and inflammatory landscape in primary brain tumours

Targeting the peripheral neural-tumour microenvironment for cancer therapy

From pain to tumor immunity: influence of peripheral sensory neurons in cancer